SLC2A10 and cancer: Furthermore, the expression of SLC2A10 was significantly correlated with the infiltration levels of DCs in 19 types of cancers, neutrophils in 16 types of cancers, CD8+ T cells in 13 types of cancers, and CD4+ T cells and B cells in 11 types of cancers.